Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.16 Bil Enterprise Value: 9.58 Bil PE Ratio: 106.36 PB Ratio: 2.73 GF Score: 85/100

Qiagen NV at TD Cowen Health Care Conference Transcript

Mar 05, 2024 / 02:10PM GMT
Release Date Price: €43.54
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst

Day 2 of the TD Cowen Global Healthcare Conference, Dan Brennan, follow tools and diagnostics. Really pleased to be joined here on the stage with me, management of QIAGEN. To my left, we have Roland Sackers, who is the CFO, and we have to his left, John Gilardi, who is Investor Relations. So gentlemen, welcome.

Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board

Thanks.

Questions & Answers

Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst

We were pleased to have you guys. A lot to tackle here. Maybe kind of -- well, let's just kick it off with Roland, you want to give us a quick backdrop on kind of Q4, maybe just look ahead to '24, kind of how you thought about the year went and maybe what are you excited about for 24?

Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot